Reaction
Wrong Schedule reporting signals
As of the last recalculation, Wrong Schedule appears in 937 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is GLECAPREVIR AND PIBRENTASVIR (PRR 43.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Glecaprevir And Pibrentasvir | 21 | 43.4 | 43.5 |
| Alirocumab | 31 | 28.4 | 28.4 |
| Galcanezumab-Gnlm | 30 | 21.8 | 21.8 |
| Ixekizumab | 28 | 17.3 | 17.3 |
| Velpatasvir And Sofosbuvir | 8 | 14.0 | 14.0 |
| Panitumumab | 7 | 10.0 | 10.0 |
| Cenobamate | 3 | 8.0 | 8.0 |
| Ledipasvir And Sofosbuvir | 6 | 7.0 | 7.0 |
| Guselkumab | 9 | 5.6 | 5.6 |